What is Pharma Mar SAU?
, a biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally. It operates through Oncology and RNA Interference segments. The company is listed on the LSE in UK, operating in the Healthcare sector, with a market capitalisation of 16.39B, and a P/E ratio of 14.7x.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.